IRVING, Texas, May 07, 2025--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...

IRVING, Texas, March 18, 2025--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company") a leading solutions provider in preventive health care through the delivery of personalized ...

This afternoon, Biote published financial results for the second quarter ended June 30, 2024. This news release is available on the Investor Relations section of the company’s website.

Biote reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always ...

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone ...

biote Corp. returned to profitability in Q3 2023 and is expected to continue to be profitable in the future. The company's growth is driven by the sale of hormone replacement therapy products and ...

Biote Corp. (BTMD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These ...

Biote has reached a $60 million settlement with its founder’s ex-wife, Marci Donovitz. The lawsuit was filed June 5 and alleged that the Irving-based hormone therapy company’s executives ...